Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
$9.77
$0.49
$2.60
$2.35B1.5539,610 shs3.45 million shs
Orion Oyj stock logo
ORINY
Orion Oyj
$33.03
+3.8%
$29.82
$19.97
$33.03
$9.32B0.172,297 shs143 shs
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
$0.50
$0.47
$0.31
$0.50
$9.30B0.51,844 shsN/A
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
$8.25
$8.74
$5.04
$11.75
$9.03B0.44689 shsN/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
0.00%0.00%0.00%0.00%0.00%
Orion Oyj stock logo
ORINY
Orion Oyj
0.00%+5.98%+16.92%+21.39%+65.15%
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
0.00%0.00%+0.30%+16.75%+57.17%
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
0.00%0.00%+18.71%-20.29%+50.27%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
N/AN/AN/AN/AN/AN/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
N/AN/AN/AN/AN/AN/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
0.00
N/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
2.00
HoldN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
0.00
N/AN/AN/A
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
$30K0.00N/AN/A$0.25 per share0.00
Orion Oyj stock logo
ORINY
Orion Oyj
$1.29B7.24$1.25 per share26.45$3.41 per share9.69
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/A
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
$4.48B2.01$0.47 per share17.62N/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
-$7.01M-$0.10N/AN/AN/A-49,910.34%-48.37%-45.25%N/A
Orion Oyj stock logo
ORINY
Orion Oyj
$234.64M$1.3126.2125.41N/A23.01%39.49%21.75%7/18/2025 (Estimated)
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/A0.00N/AN/AN/AN/A6/4/2025 (Estimated)
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
$155.35MN/A0.00N/AN/AN/AN/AN/A

Latest BLUSF, SBMFF, SNPTF, and ORINY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2025Q1 2025
Orion Oyj stock logo
ORINY
Orion Oyj
N/A$0.23N/A$0.23N/A$373.03 million
2/25/2025Q4 2024
Orion Oyj stock logo
ORINY
Orion Oyj
N/A$0.28N/A$0.28N/A$463.41 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
N/AN/AN/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
$0.320.97%N/A24.43%N/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/A
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
N/AN/AN/AN/AN/A

Latest BLUSF, SBMFF, SNPTF, and ORINY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/17/2025
Orion Oyj stock logo
ORINY
Orion Oyj
$0.44784/7/20254/7/20254/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
N/A
13.87
13.87
Orion Oyj stock logo
ORINY
Orion Oyj
0.25
2.42
1.41
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
0.02
1.15
1.07
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
0.20
1.76
1.51
CompanyEmployeesShares OutstandingFree FloatOptionable
BELLUS Health Inc stock logo
BLUSF
BELLUS Health
10159.12 millionN/ANot Optionable
Orion Oyj stock logo
ORINY
Orion Oyj
3,632282.27 millionN/ANot Optionable
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
25,80618.79 billionN/ANot Optionable
Sunny Optical Technology (Group) Company Limited stock logo
SNPTF
Sunny Optical Technology (Group)
29,5241.09 billionN/ANot Optionable

Recent News About These Companies

Sunny Optical Technology (Group) Co (SNPTF) Gets a Buy from DBS
Sunny Optical Technology (Group) Co (SNPTF) Receives a Buy from DBS
DBS Remains a Buy on Sunny Optical Technology (Group) Co (SNPTF)
DBS Keeps Their Buy Rating on Sunny Optical Technology (Group) Co (SNPTF)
Sunny Optical Sees Diverse Growth in October Shipments
Keysight Technologies to acquire Optical Solutions Group from Synopsys
3 SEHK Stocks That May Be Undervalued In September 2024
Sunny Optical Technology (Group) Company Limited (SXC0.MU)

Media Sentiment Over Time

BELLUS Health stock logo

BELLUS Health OTCMKTS:BLUSF

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Orion Oyj stock logo

Orion Oyj OTCMKTS:ORINY

$33.03 +1.22 (+3.84%)
As of 05/22/2025 03:56 PM Eastern

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. Further, the company has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.

Sino Biopharmaceutical stock logo

Sino Biopharmaceutical OTCMKTS:SBMFF

$0.50 0.00 (0.00%)
As of 05/22/2025

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand. It also provides surgery/analgesia medicines, including flurbiprofen cataplasms under the brand Zepolas, limaprost tablets under the brand Kailitong, and recombinant human coagulation factor VIII for injection under the brand Anhengji; cardio-cerebral vascular medicines, such as irbesartan and hydrochlorothiazide tablets under the brand Yilunping and beraprost sodium tablets under the brand Kaina; and biosimilar medicines comprising adalimumab solution for injection under the brand Taibowei. In addition, the company develops oncology drugs, include benmelstobart, D-1553, TQ-B3139, and TQ-B3101; liver disease drugs, such as Lanifibranor and TQA2225/AP025; respiratory system drugs comprising TDI01, TQC2731, TCR1672, TQC3721, and TQH2722; and surgery/analgesia drugs, including PL-5, an antimicrobial peptide. Further, it is involved in the long-term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Sunny Optical Technology (Group) stock logo

Sunny Optical Technology (Group) OTCMKTS:SNPTF

$8.25 0.00 (0.00%)
As of 05/22/2025

Sunny Optical Technology (Group) Company Limited, an investment holding company, engages in designing, researching, developing, manufacturing, and selling optical and optical related products, and scientific instruments. The company's Optical Components segment offers glass spherical and aspherical lenses, handset lens sets, vehicle lens sets, security surveillance lens sets, and other lens sets. Its Optoelectronic Products segment comprise handset camera modules, three dimensional optoelectronic products, vehicle modules, and other optoelectronic modules. The company's Optical Instruments segment includes microscopes and intelligent inspection equipment for testing. Its optoelectronic-related products are used in handsets, digital cameras, vehicle imaging and sensing systems, security surveillance systems, virtual reality/augmented reality, and robots, which are combined with optical, electronic, algorithm, and mechanical technologies. In addition, the company engages in the research and development of infrared and semiconductor technologies; trading of optical instruments and optoelectronics products; property leasing activities; and development, service, and consultation of technology; provision of financing services; and import and export agency services. It operates primarily in the People's Republic of China, rest of Asia, Europe, North America, and internationally. The company was founded in 1984 and is headquartered in Yuyao, China.